Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$188,264
New position
Shares Held
29,098
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 9%
Shared 0%
None 91%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MERCER GLOBAL ADVISORS INC /ADV holds $43,515,258 across 26 Drug Manufacturers - Specialty & Generic names. TLRY ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
20,166 | $11,958,034 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
60,275 | $7,940,628 | |
| 3 | ZTS |
Zoetis Inc.
|
55,270 | $6,533,466 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
172,961 | $3,203,237 | |
| 5 | HLN |
Haleon plc
|
293,965 | $2,942,589 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,408 | $2,120,688 | |
| 7 | VTRS |
Viatris Inc
|
146,854 | $1,983,997 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
78,205 | $1,871,445 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $188,264 | 29,098 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||